tiprankstipranks
Trending News
More News >
Ascendis Pharma (ASND)
NASDAQ:ASND
US Market
Advertisement

Ascendis Pharma (ASND) Technical Analysis

Compare
668 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
5Neutral
3Bearish
Technical Analysis Consensus
Buy
4Bullish
5Neutral
1Bearish
Moving Average Consensus
Strong Buy
10Bullish
0Neutral
2Bearish
Ascendis Pharma’s (ASND) Moving Averages Convergence Divergence (MACD) indicator is 2.29, suggesting Ascendis Pharma is a Sell.
Ascendis Pharma’s (ASND) 20-Day exponential moving average is 205.99, while Ascendis Pharma’s (ASND) share price is $209.55, making it a Buy.
Ascendis Pharma’s (ASND) 50-Day exponential moving average is 202.10, while Ascendis Pharma’s (ASND) share price is $209.55, making it a Buy.

Ascendis Pharma (ASND) Pivot Points

Nov 22, 2025, 08:21 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
197.66
202.84
207.49
212.67
217.32
222.50
227.15
Fibonacci
202.84
206.59
208.91
212.67
216.42
218.74
222.50
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Ascendis Pharma (ASND) Moving Averages

Nov 22, 2025, 08:21 AM
Period
Simple
Exponential
MA5
211.96Sell
210.58Sell
MA10
206.04Buy
208.18Buy
MA20
204.44Buy
205.99Buy
MA50
202.89Buy
202.10Buy
MA100
193.70Buy
193.81Buy
MA200
176.00Buy
176.11Buy
Ascendis Pharma’s (ASND) 10-Day exponential moving average is 208.18, while Ascendis Pharma’s (ASND) share price is $209.55, making it a Buy.
Ascendis Pharma’s (ASND) 100-Day exponential moving average is 193.81, while Ascendis Pharma’s (ASND) share price is $209.55, making it a Buy.
Ascendis Pharma’s (ASND) stock price is $209.55 and Ascendis Pharma’s (ASND) 50-day simple moving average is 202.89, creating a Buy signal.
Ascendis Pharma’s (ASND) stock price is $209.55 and Ascendis Pharma’s (ASND) 100-day simple moving average is 193.70, creating a Buy signal.
Ascendis Pharma’s (ASND) stock price is $209.55 and Ascendis Pharma’s (ASND) 200-day simple moving average is 176.00, creating a Buy signal.

Ascendis Pharma (ASND) Technical Indicators

Nov 22, 2025, 08:21 AM
Name
Value
Implied Action
RSI (14)
54.76
Neutral
STOCH (9,6)
70.83
Neutral
STOCHRSI (14)
70.83
Neutral
MACD (12,26)
2.29
Sell
ADX (14)
12.39
Buy
Williams %R
-38.83
Buy
CCI (14)
97.71
Neutral
ATR (14)
9.33
-
Ultimate Oscillator
48.87
Neutral
ROC
3.94
Buy
Ascendis Pharma’s (ASND) Relative Strength Index (RSI) is 54.76, creating a Neutral signal.
Ascendis Pharma’s (ASND) Trend Strength Indicator (ADX) is 12.39, creating a Buy signal.
Ascendis Pharma’s (ASND) Commodity Channel Index (CCI) is 97.71, creating a Neutral signal.
Ascendis Pharma’s (ASND) Price Rate of Change (ROC) is 3.94, creating a Buy signal.

FAQ

Is ASND a Buy, Hold, or Sell?
Based on ASND’s technical indicators, ASND is a Buy.
    What is ASND’s RSI (14)?
    ASND’s RSI (14) is 54.76, which suggests ASND is a Neutral.
      What is ASND’s MACD?
      ASND’s MACD is 2.29, which suggests ASND is a Sell.
        What is ASND’s 5-day moving average?
        ASND’s 5-day moving average is 211.96, which suggests ASND is a Sell.
          What is ASND’s 20-day moving average?
          ASND 20-day moving average is 204.44, which suggests ASND is a Buy.
            What is ASND’s 50-day moving average?
            ASND’s 50-day moving average is 202.89, which suggests ASND is a Buy.
              What is ASND’s 200-day moving average?
              ASND’s 200-day moving average is 176.00, which suggests ASND is a Buy.
                What is ASND’s Williams % R (14)?
                ASND’s Williams % R (14) is -38.83, which suggests ASND is a Buy.
                  What is ASND’s CCI (14)?
                  ASND’s CCI (14) is 97.71, which suggests ASND is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis